ARA-290
One of the few peptides in this field to have reached controlled human studies.
| Property | Value |
|---|---|
| Type | Peptide, 11 amino acids |
| Origin | Modelled on part of EPO |
| Research field | Nerve pain, small nerve fibres, tissue inflammation |
| Research status | Phase 2 human studies conducted |
| Form | Freeze dried powder |
What it is
EPO is the hormone driving red blood cell production. It also has a protective action in tissue, through a different receptor. ARA-290 is designed so that only that second route remains.
How it works
It acts on the so-called tissue protective receptor, a combination of two receptor parts separate from the blood forming route. The effect on red blood cells therefore does not occur, which was the very objection to EPO itself.
What the research shows
Controlled human studies have been run, including in sarcoidosis with small fibre complaints. That puts the level of evidence above most substances in this field.
Research status
Clinically studied through phase 2.
Practical
Dissolves normally in bacteriostatic water, keep the powder in a freezer.
This site is made by the team behind Apex Bio Research, a Dutch supplier of research peptides with a certificate of analysis per batch.
Visit the shopThis site explains what the scientific literature says about peptides. It is not medical advice and not a set of instructions. The substances discussed here are research compounds: they are not approved for use in humans or animals. If you have a health question, see a doctor.